Header Logo

Connection

Michael Messina to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Michael Messina has written about Drug Administration Schedule.
Michael Messina
Connection Strength
0.070
Drug Administration Schedule
  1. Messina MP, Rauktys A, Lee L, Dabora SL. Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779. BMC Pharmacol. 2007 Nov 06; 7:14.
    View in: PubMed
    Score: 0.070
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.